A method for preparing 3-phenyl-[1,2,4]triazol[4,3-a]pyridine compounds without metal catalysis
A metal-free catalyst and compound technology, applied in the direction of organic chemistry, can solve the problems of complete removal of toxic catalysts, many reaction steps, and low reaction efficiency, and achieve the prospect of large-scale industrial application, convenient post-processing, and easy-to-obtain raw materials Effect
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0023] Embodiment 1: the preparation of product 4a
[0024]
[0025] At room temperature, 395 mg (5 mmol) of pyridine 1a, 390 mg (6 mmol) of sodium azide 2 and 530 mg (5 mmol) of benzaldehyde 3a were added to a 25 mL round-bottomed flask, followed by 15 mL of ether and 900 mg (10 mmol) of tert- Butyl hydroperoxide, stirred at 25°C for 6 hours. After the reaction is complete, add 15 mL of saturated aqueous sodium chloride solution to the system, extract 3 times with ethyl acetate, 10 mL each time, combine the organic phases, dry with anhydrous sodium sulfate, evaporate the solvent, and perform 200-300 mesh silica gel column chromatography The pure product of 4a was obtained (781 mg, 80% yield, pale yellow solid).
[0026] 1 H NMR (400MHz, CDCl 3 ):δ8.56(d,J=7.0Hz,1H),7.91(d,J=6.5Hz,2H),7.81(d,J=9.3Hz,1H),7.59-7.65(m,3H),7.41 -7.45(m,1H), 7.02(t,J=6.7Hz,1H).
[0027] 13 C NMR (100MHz, CDCl 3 ): δ150.0, 146.0, 129.9, 129.2, 128.0, 127.9, 126.6, 123.8, 115.6, 114.4.
Embodiment 2
[0028] Embodiment 2: the preparation of product 4b
[0029]
[0030] At room temperature, 395mg (5mmol) of pyridine 1a, 390mg (6mmol) of sodium azide 2 and 600mg (5mmol) of p-tolualdehyde 3b were added to a 25mL round bottom flask, and then 15mL of ether and 900mg (10mmol) of ) of tert-butyl hydroperoxide, stirred at 25°C for 6 hours. After the reaction is complete, add 15 mL of saturated aqueous sodium chloride solution to the system, extract 3 times with ethyl acetate, 10 mL each time, combine the organic phases, dry with anhydrous sodium sulfate, evaporate the solvent, and perform 200-300 mesh silica gel column chromatography The pure product of 4b was obtained (857 mg, 82% yield, pale yellow solid).
[0031] 1 H NMR (400MHz, CDCl 3 ): δ8.26(d, J=7.1Hz, 1H), 7.82(d, J=9.3 Hz, 1H), 7.72(d, J=8.2Hz, 2H), 7.39(d, J=7.9Hz, 2H ),7.24-7.29(m, 2H),6.85(t,J=6.4Hz,1H),2.47(s,3H).
[0032] 13 C NMR (100MHz, CDCl 3 ): δ140.6, 130.1, 128.3, 127.0, 124.0, 123.9, 122.8, 117.0, ...
Embodiment 3
[0033] Embodiment 3: the preparation of product 4c
[0034]
[0035] At room temperature, add 395mg (5mmol) of pyridine 1a, 390mg (6mmol) of sodium azide 2 and 670mg (5mmol) of 3,4-dimethylbenzaldehyde 3c into a 25mL round bottom flask respectively, and then add 15mL of diethyl ether in sequence and 900 mg (10 mmol) of tert-butyl hydroperoxide, and stirred at 25° C. for 6 hours. After the reaction is complete, add 15 mL of saturated aqueous sodium chloride solution to the system, extract 3 times with ethyl acetate, 10 mL each time, combine the organic phases, dry with anhydrous sodium sulfate, evaporate the solvent, and perform 200-300 mesh silica gel column chromatography The pure product of 4c was obtained (1038 mg, 93% yield, pale yellow solid).
[0036] 1 H NMR (400MHz, CDCl 3):δ8.28(d,J=7.1Hz,1H),7.82(d,J=9.3Hz,1H),7.41(s,1H),7.32-7.35(m,1H),7.25-7.29(m, 1H),7.05(d,J=8.3Hz,1H),6.85(t,J=7.3Hz,1H),3.97(s,3H),3.97(s,3H).
[0037] 13 C NMR (100MHz, CDCl 3 ): δ150.8,...
PUM
Login to View More Abstract
Description
Claims
Application Information
Login to View More 
![A method for preparing 3-phenyl-[1,2,4]triazol[4,3-a]pyridine compounds without metal catalysis](https://images-eureka.patsnap.com/patent_img/15c3ed8c-4c1d-4daf-add0-f28605a4b229/BDA0002071642390000021.png)
![A method for preparing 3-phenyl-[1,2,4]triazol[4,3-a]pyridine compounds without metal catalysis](https://images-eureka.patsnap.com/patent_img/15c3ed8c-4c1d-4daf-add0-f28605a4b229/BDA0002071642390000041.png)
![A method for preparing 3-phenyl-[1,2,4]triazol[4,3-a]pyridine compounds without metal catalysis](https://images-eureka.patsnap.com/patent_img/15c3ed8c-4c1d-4daf-add0-f28605a4b229/BDA0002071642390000051.png)